Javascript must be enabled to continue!
Combined IFN-β and PLT Detection Can Identify Kawasaki Disease Efficiently
View through CrossRef
Objective: To evaluate the value of combined interferon β (IFN-β) and platelet (PLT) detection for Kawasaki disease (KD) identification.Methods: Forty-four children who were newly diagnosed with KD were selected as the KD group. They were divided into acute phase of KD and subacute phase of KD. They were also separated into groups with and without coronary artery disease (CAD) (CAD+ and CAD–, respectively). Meanwhile, 44 children hospitalized with febrile disease and 44 healthy children were selected as a febrile control group and normal control group, whom were attended to at Children's Hospital of Soochow University at the same time. We detected the concentration of IFN-β and PLT of peripheral blood serum for all three groups and analyzed the difference.Results: At acute and subacute phases of KD, both IFN-β and PLT are higher than both the febrile control group and healthy control group, especially at subacute phase; the difference between groups was statistically significant, P < 0.05. Receiver operating characteristic (ROC) curve showed that the areas under the ROC curve (AUCs) of IFN-β and PLT at acute phase of KD were 0.81 and 0.72, respectively; the sensitivity and specificity were 97.22 and 63.64%, and 57.89 and 73.86%, respectively. The AUCs of combined IFN-β and PLT were 0.81 at acute phase and 0.96 at subacute phase of KD, with sensitivity and specificity of 97.22 and 55.26%, and 86.36 and 100%, respectively. The cutoff value of combined IFN-β and PLT detection was IFN-β = 3.51 pg/ml and PLT = 303 × 109/L at acute phase of KD, IFN-β = 4.21 pg/ml and PLT = 368 × 109/L at subacute phase from plot vs. criterion values. However, there are no significant differences between the CAD– group and the CAD+ group for combined IFN-β and PLT, both P > 0.5, neither at acute nor at subacute phase of KD.Conclusion: Combined IFN-β and PLT detection is an efficient biomarker for KD identification. The cutoff values are IFN-β = 3.51 pg/ml and PLT = 303 × 109/L at acute phase of KD and IFN-β = 4.21 pg/ml and PLT = 368 × 109/L at subacute phase.
Frontiers Media SA
Title: Combined IFN-β and PLT Detection Can Identify Kawasaki Disease Efficiently
Description:
Objective: To evaluate the value of combined interferon β (IFN-β) and platelet (PLT) detection for Kawasaki disease (KD) identification.
Methods: Forty-four children who were newly diagnosed with KD were selected as the KD group.
They were divided into acute phase of KD and subacute phase of KD.
They were also separated into groups with and without coronary artery disease (CAD) (CAD+ and CAD–, respectively).
Meanwhile, 44 children hospitalized with febrile disease and 44 healthy children were selected as a febrile control group and normal control group, whom were attended to at Children's Hospital of Soochow University at the same time.
We detected the concentration of IFN-β and PLT of peripheral blood serum for all three groups and analyzed the difference.
Results: At acute and subacute phases of KD, both IFN-β and PLT are higher than both the febrile control group and healthy control group, especially at subacute phase; the difference between groups was statistically significant, P < 0.
05.
Receiver operating characteristic (ROC) curve showed that the areas under the ROC curve (AUCs) of IFN-β and PLT at acute phase of KD were 0.
81 and 0.
72, respectively; the sensitivity and specificity were 97.
22 and 63.
64%, and 57.
89 and 73.
86%, respectively.
The AUCs of combined IFN-β and PLT were 0.
81 at acute phase and 0.
96 at subacute phase of KD, with sensitivity and specificity of 97.
22 and 55.
26%, and 86.
36 and 100%, respectively.
The cutoff value of combined IFN-β and PLT detection was IFN-β = 3.
51 pg/ml and PLT = 303 × 109/L at acute phase of KD, IFN-β = 4.
21 pg/ml and PLT = 368 × 109/L at subacute phase from plot vs.
criterion values.
However, there are no significant differences between the CAD– group and the CAD+ group for combined IFN-β and PLT, both P > 0.
5, neither at acute nor at subacute phase of KD.
Conclusion: Combined IFN-β and PLT detection is an efficient biomarker for KD identification.
The cutoff values are IFN-β = 3.
51 pg/ml and PLT = 303 × 109/L at acute phase of KD and IFN-β = 4.
21 pg/ml and PLT = 368 × 109/L at subacute phase.
Related Results
Incidence of Antibodies to Protamine/Heparin Complexes in Cardiac Surgery Patients and Impact on Platelet Activation in Vitro and Clinical Outcome
Incidence of Antibodies to Protamine/Heparin Complexes in Cardiac Surgery Patients and Impact on Platelet Activation in Vitro and Clinical Outcome
Abstract
Abstract 2217
Introduction, aims of the study:
Cardiac surgery (CS) is associated with high risk of anti...
Long-Term Interferon-α Treatment in Essential Thrombocythemia
Long-Term Interferon-α Treatment in Essential Thrombocythemia
Abstract
Background: Essential thrombocythemia (ET) is a chronic myeloid stem cell disorder characterized by an uncontrolled production of platelets....
P11.01 TMZ-LEV- IFN cocktail regimen significantly inhibited the growth of glioma
P11.01 TMZ-LEV- IFN cocktail regimen significantly inhibited the growth of glioma
Abstract
BACKGROUND
TMZ, is the first line chemotherapeutic drug for glioma, and drug resistance is one of the most important re...
Does the interferon-lambda rather than the interferon-alpha pathway determine the outcome of hepatitis C virus infection?
Does the interferon-lambda rather than the interferon-alpha pathway determine the outcome of hepatitis C virus infection?
Abstract
The molecular mechanisms that link IFN-λ3 genotypes to differential induction of interferon (IFN)-stimulated genes (ISGs) in the liver of patients with chronic...
The Application of Eltrombopag to Promote Platelet Engraftment after Allogeneic Hematopoietic Stem Cell Transplantation
The Application of Eltrombopag to Promote Platelet Engraftment after Allogeneic Hematopoietic Stem Cell Transplantation
Abstract
Background :
Eltrombopag is an agonist of the thrombopoietin receptor, and it has achieved great efficacy in the treatment of immunologic thr...
Inhibition of hepatitis B virus DNA replication by a thermostable interferon-γ variant
Inhibition of hepatitis B virus DNA replication by a thermostable interferon-γ variant
Background Treatment of HBV chronic carriers using interferon (IFN)-α or nucleoside/nucleotide analogues fails to suppress viral infection. Type-II IFN-γ has been shown to inhibit ...
Interferon‐βMediates Opposing Effects on Interferon‐γ‐dependent Interleukin‐12 p70 Secretion by Human Monocyte‐Derived Dendritic Cells
Interferon‐βMediates Opposing Effects on Interferon‐γ‐dependent Interleukin‐12 p70 Secretion by Human Monocyte‐Derived Dendritic Cells
AbstractInterferon‐β(IFN‐β) exposure during tumour necrosis factor‐α(TNF‐α)‐induced human monocyte‐derived dendritic cell (DC) maturation augments the capacity of DC to promote the...
A Review on Kawasaki Disease
A Review on Kawasaki Disease
Kawasaki disease is an acute, self-limited vasculitis of unknown etiology, which mainly occurs in infants and children. The target organs of Kawasaki disease are coronary arteries ...

